Hôpital Edouard Herriot, CHU de Lyon

Lyon, Auvergne-Rhône-Alpes 69003

0 studies enrolling now · 1 studies all time

What they study most

Sickle Cell Disease

Studies at this site

• A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD) — Running, not enrolling